Drugs / Fluarix/Influsplit SSW
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01884519 | Jul → Aug 2013 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluarix/Influsplit SSW | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01884519 ↗ |
| Modality | Vaccine | “seasonal influenza vaccine” NCT01884519 ↗ |
| Route | Intramuscular | “administered intramuscularly (or deeply subcutaneously)” NCT01884519 ↗ |
| Route | Subcutaneous | “administered intramuscularly (or deeply subcutaneously)” NCT01884519 ↗ |